1. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Lifetime risk of different cancer in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995; 64:430-433
2. Berg JM, Tymoczko JL, Stryer L, Kohlenhydrate. In: Berg JM, Tymoczko JL, Stryer L, eds. Biochemie. Heidelberg – Berlin: Spektrum Akademischer Verlag GmbH, 2003: 523-547
3. Lin J, Zhang SM, Cook NR, Rexrode KM, Liu S, Manson JE, Lee IM, Buring JE.
Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of woman (United States). Cancer Causes Control 2005;
16(3):225-233
4. Blumberg D, Paty PB, Guillem J G, Picon A I, Minsky BD, Wong WD, Cohen AM.
All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum 1999; 42(7):881-885
5. Braumann D, Dörner A, Drescher S, Goth B, de Heer K, Heilmann HP, Höcht ST, Kleeberg UR, Kußmann J, Matthaei P, Rückert K, Schorcht J, Zornig C. Leitlinien zur kurativen Behandlung des Kolon- und des Rektumkarzinoms 1999
6. Broders AC. The grading of carcinoma. Minn Med 1925; 8:726-730
7. Brodsky JT, Richard GK, Cohen AM, Minsky BD. Variables correlated with he risk of lymph node metastasis in early rectal cancer. Cancer 1992; 15(2):322-326
8. Buchmann P. Standard technique of oncologic colorectal surgery. Swiss Surg.
2003; 9(3):140-144
9. Bülow S. Clinical features in familial polyposis coli. Results of the Danish Polyposis Register. Dis Colon Rectum 1986; 29(2):102-107
10. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fleding LP. American joint Comitee on Cancer prognostic factors consensus conference colorectal working group. Cancer 2000; 88:1739-1757
11. Connell WR, Talbot IC, Harpaz N, Britto N, Wilkinson KH, Kamm MA, Lennard-Jones JE. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994; 35:1419-1423
12. Corsale I, Foglia E, Mandato M, Aloise F, Rigutini M, Bartolomei M. Management of the neoplastic stenosis of the left colon with self-expandable endoprosthesis. G Chir 2003; 24(11-12):418-421
13. Degiuli M, Mineccia M, Bertone A, Arrigoni A, Pennazio M, Spandre M, Cavallero M, Calvo F. Outcome of laparoscopic colorectal resection. Surg Endosc 2004;
18(3):427-432
14. Deinlein P, Reulbach U, Stolte M, Vieth M. Risikofaktoren der lymphogenen Metastasierung von kolorektalen pT1-Karzinomen. Der Pathologe 2003; 24:387-393
15. Deutsche Krebsgesellschaft, deutsche Gesellschaft für Chirurgie, deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten – AWMF Leitlinien 2004; Register Nr. 32/30
16. D'Souza DN, Pera M, Nelson H, Finical SJ, Tran NV. Vaginal reconstruction following resection of primary locally advanced and recurrent colorectal malignancies. Arch Surg 2003; 138(12):1340-1343
17. Eisele R. Kolorektales Karzinom Neue Behandlungsansätze - Chirurgische Therapie – Leitlinien Ärztekammer Baden Württemberg 2004
18. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn‘s disease with colonic involvement. Lancet 1990; 336:357-359
19. Fielding LP, Arsenault PA, Chapuis PH, Dent O, Gatright B, Hardcastle JD, Hermanek P et al. Clinico- pathological staging for colorectal cancer. International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 1990; 6:325–344
20. Fodde R. The APC Gene in colorectal cancer. Eur J Cancer 2002; 38(7):867-871
21. Fogt F, Zimmermann RL, Ross HM, Daly T, Gausas RE. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncolology Reports 2004; 11:47-50
22. Fogt F, Pascha Tl, Zhang PJ, Gausas RE, Rahemtulla A, Zimmerman RL.
Proliferation of D2-40-expressing intestinal lymphatic vessels in the lamina propria in inflammatory bowel disease. Int J Med 2004; 13(2):211-221
23. Garcia-Aguilar J, Mellgren A, Sirivongs P, Buie D, Madoff RD, Rothenbergre DA.
Local excision of rectal cancer without adjuvant therapy. Ann Surg 2000;
231(3):345-351
24. Goddart MJ, Wilson B, Grant JW. Comparison of commercially available cytokeratin antibodies in normal and neoplastic adult epithelial and non – epithelial tissues. J Clin Pathol 1991; 44:660 - 663
25. Hermanek P. A pathologist`s point of view on endoscopically removed polyps of colon and rectum. Acta Hepatocastroenterol 1978; 25:169-170
26. Herold G, Heintges T, Kolorektales Karzinom. In: Herold G, ed. Innere Medizin.
Köln: Dr.med.Gerd Herold, 2006: 426-431
27. Herranz Amo F, Munoz Jimenez F, Subira Rios D, Gomez Espi M, Calvo Manuel FA. Preservation of the bladder in rectal cancer with prostatic invasion. Actas Urol Esp. 2004; 28(6):447-451
28. Hildebrandt U, Kreissler-Haag D, Lindemann W. Laparoscopy-assisted colorectal resections: morbidity, conversions, outcomes of a decade. Zentralbl Chir 2001;
126(4):323-332
29. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Zytochem 1981; 29:577-580
30. Ichii S, Takeda S, Horii A, Nakatsuru S, Miyoshi Y, Emi M, Fujiwara Y, Koyama K, Furuyama J, Utsunomiya J, Nakamura Y. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familialadenomatous polyposis (FAP). Oncogene 1993; 8:2399–2405
31. Jacques C, de Aquino AM, Ramos-e-Silva M. Cytokeratins and dermatology.
Skinmed. Nov – Dec 2005; 4(6):354-360
32. Jass JA, Atkin WS, Cuzick J, Bussey HJ, Morson BC, Northover JM, Todd IP.
The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986; 10:437-459
33. Junck M. Hereditary carcinoma: pathogenesis and diagnosis. Zentralbl Chir 2000;
(125) Suppl 1:8-11
34. Kahn HJ, Marks A. A New monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Laboratory Investigation 2002; 82(9):1255-1257
35. Kaiserling E. Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology. Pathologe 2004; 25(5):362-374
36. Kanellos D, Kitsios G, Kanellos I, Demetriades H, Pramateftakis MG, Angelopoulos S, Betsis D. Anaemia as a symptom of right colon cancer Tech Coloproctol 2004; 8 Suppl 1:62-64
37. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y.
Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995; 38:1286-1295
38. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumura Y, Kishi N, Iwama T, Mori T, Koike M, Ushio K, Chiba M, Nomizu S, Konishi F, Utsunomiya J, Miyaki M. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer.
Gastroenterology 1996; 111:307–317
39. Kudo S. Endscopical mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy 1993; 25:455-461
40. Lippert H, Kolon und Rektumkarzinom. In: Hirner A, Weise K eds. Chirurgie Schnitt für Schnitt. Stuttgart - New York: Georg Thieme, 2004: 616-619
41. Minsky BD, Mies C, Recht A, Rich TA, Chaffey JT. Resectible Adenokarcinoma of the rectosigmoid and rectum. The influence of blood vessel invasion. Cancer 1988; 61:1417-1424
42. Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Igari T, Tanaka K, Muraoka M, Takahashi H, Amada Y, Fukayama M, Maeda Y, Iwama T, Mishima Y, Mori T, Koike M. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 1994; 54:3011–3020
43. Moll R. Cytokeratins as makers of differentation in the diagnosis of epithelial tumors. Subcellular Biochemistry 1998; 31:205-262
44. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular β - catenin levels by the adenomatous polyposis coli (APC) tumorsuppressor protein. Proc Natl Acad Sci USA 1995; 92:3046–3050
45. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002;
45:200-206
46. Nicholson AG, Graham ANJ, Pezzella F, Agnetha G, Goldstraw P, Pastorino U.
The use of immunohistochemistry to identify micrometastasis provide useful information in the staging of node-negative non-small cell lung carcinomas? Lung cancer 1997; 18:231-240
47. Nürnberg D, Nürnberg S, Schneider C, Vorreiter G. Kolorektale Karzinome 2003-2004. Onkologischer Sachbericht 2005: 102-120
48. Onder G, D'Arco C, Fusco D, Bernabei R. Preoperative assessment and risk factors in the surgical treatment of lung cancer: the role of age. Rays 2004 Oct-Dec; 29(4):407-411
49. Otto H F, Kolon und Rectum. In: Böcker W, Denk H, Heitz P U, eds. Pathologie.
München - Jena: Urban & Fischer, 2001: 691-696
50. Rubinfeld B, Souza B, Albert I, Müller O, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P. Association of the APC gene product with β-catenin.
Science 1993; 262:1731–1734
51. Sitzler PJ, Seow-Choen F, Ho YH, Leong AP. Lymph node involvement and tumor depth in rectal cancers: analysis in 805 patients. Dis Colon Rectum 1997;
40(12):1472-1476
52. Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV, Gallinger S. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.
Cancer Res 1994; 54:5527–5530
53. Stief CG, Jonas U, Raab R. Long-term follow-up after surgery for advanced colorectal carcinoma involving the urogenital tract. Eur Urol 2002; 41(5):546-550
54. Stolte M, Gastroenterologische Endoskopie. In: Frühmorgen P, ed.
Gastroenterologie und Pathologie, Ein Leitfaden zur Diagnostik und Therapie.
Berlin – Heidelberg - New York: Springer, 1992: 67-92
55. Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004;
95(6):475-480
56. Turnbull RB Jr, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. CA Cancer J Clin 1968 Mar-Apr;
18(2):82-87
57. UICC 2002. In: Wittekind CH, Meyer HJ, Bootz F, eds. TNM-Klassifikation maligner Tumoren. Berlin – Heidelberg - New York: Springer, 2005: 49-54